Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

DNA bubbles illustration

A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

Primate Genome A.I. Model IDs Human Disease Variants

Mandrill, a primate species

A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans. . . . → Read More: Primate Genome A.I. Model IDs Human Disease Variants

Crispr Therapy Shown to Reduce Harmful Gut Microbes

E. coli bacteria illustration

A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes

Precision T-Cell Solid Tumor Therapy Trial Underway

T lymphocyte

A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells. . . . → Read More: Precision T-Cell Solid Tumor Therapy Trial Underway

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

T-cells and cancer cells

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Editing DNA

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

$60M Challenge Seeks Biomarkers, Models to Counter Aging Stress

Older cyclist on a bicycle path

A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death. . . . → Read More: $60M Challenge Seeks Biomarkers, Models to Counter Aging Stress

Biotech, Janssen Partner on Ultrasound for Gene Therapy

Small bubbles

A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments. . . . → Read More: Biotech, Janssen Partner on Ultrasound for Gene Therapy

Rare Disease Search Adds Large Language Model A.I.

Artificial intelligence graphic

A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I.

Computational Drug Discovery Company Acquires A.I. Businesses

Synthetic biology

Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses